Eagle Strategies’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Eagle Strategies’s Portfolio IBDQ Stock Details IBDQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,816	Closed	-$272K	–	252
2025 Q3	$272K	Buy	10,816 +48	+0.4%	+$1.21K	0.04%	218
2025 Q2	$271K	Buy	10,768 +47	+0.4%	+$1.18K	0.04%	198
2025 Q1	$270K	Buy	10,721 +30	+0.3%	+$753	0.05%	190
2024 Q4	$268K	Buy	10,691 +185	+2%	+$4.63K	0.05%	183
2024 Q3	$264K	Buy	10,506 +43	+0.4%	+$1.07K	0.05%	182
2024 Q2	$260K	Buy	+10,463	New	+$259K	0.05%	179

Other funds holding IBDQ

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eagle Strategies's IBDQ Position: Q4 2025 in Review

Eagle Strategies sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 10,816 shares — an estimated $272K sold.

Eagle Strategies first reported a position in IBDQ in Q2 2024 and held it in 6 quarters. The position peaked at $272K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

Eagle Strategies reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
Eagle Strategies sold 10,816 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $272K.
Eagle Strategies first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q2 2024 and held it in 6 quarters.
Eagle Strategies's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $272K in Q3 2025.
3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Eagle Strategies's 13F filing for Q4 2025, filed 23 Jan 2026.